PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Brand new state-of-the-art Nemera offices inaugurated in Lyon

Located in the bio district of Gerland, the BREEAM-certified collaborative space will house Nemera’s headquarters & European innovation teams.

Morning coffee on the rooftop taking in a view of beautiful Lyon, a modern mix of open-plan designs, quiet areas, lots of collaborative space and state-of-the-art technology: just some of the features of Nemera’s brand new premises in Lyon, developed from the ground up by and for the Nemera teams.

“We’re excited to bring our teams together in such a great environment. The best thing about our new offices is how reflective of our culture they are – warm, welcoming and built as a team. This strategic move brings us closer to our ecosystem – customers, academic institutions and other healthcare stakeholders. A new chapter for Nemera begins with this change further strengthening its commitment to bringing superior value to customers and patients” said Marc Hämel, CEO of Nemera.

Elizabeth de Longeaux, Vice President of Human Resources said, “Our new offices are being unveiled at a time when a lot of companies are navigating how much and what kind of spaces, they’ll need post-COVID. Our top priority was to create offices where our teams feel at their best and are most comfortable working. It’s their insights that helped us craft offices adapted to their needs. And to see the positive reaction of the teams discovering their new offices was the best gift ever.”

About Nemera
As a world-leading drug delivery device solutions provider, our purpose of putting patients first enables us to design and manufacture devices that maximize treatment efficacy.

We are a holistic partner and help our customers succeed in the sprint to market their combination products. From early device strategy to state-of-the-art manufacturing, we’re committed to the highest quality standards.

Agile and open-minded, we work with our customers as colleagues. Together, we go the extra mile to fulfil our mission. Get in touch with us at Nemera | We put patients first

Contact:
Niyati Sapatnekar
Global Communications Manager
niyati.sapatnekar@nemera.net
+33 689 31 87 33

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026